BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 17786792)

  • 1. Transient thrombocytopenia with large platelets in Kawasaki disease.
    Asano T; Sudoh M; Watanabe M; Fujino O
    Pediatr Hematol Oncol; 2007; 24(7):551-4. PubMed ID: 17786792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thrombocytopenia in Kawasaki disease: a risk factor for the development of coronary artery aneurysms.
    Nofech-Mozes Y; Garty BZ
    Pediatr Hematol Oncol; 2003 Dec; 20(8):597-601. PubMed ID: 14578029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kawasaki disease presenting with disseminated intravascular coagulation: report of one case.
    Huang LW; Sun W; Huang FY
    Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1994; 35(4):341-4. PubMed ID: 8085458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kawasaki disease.
    Soman M; Faulkner S; Snively GG
    J Fam Pract; 1983 Apr; 16(4):723-6. PubMed ID: 6833960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [New therapeutic aspects in Kawasaki syndrome and personal experiences].
    Neudorf U
    Infusionsther Transfusionsmed; 1993 Apr; 20 Suppl 1():137-9. PubMed ID: 8499743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The experience with 113 patients with Kawasaki disease in Fars Province, Iran.
    Asadi-Pooya AA; Borzoee M; Amoozgar H
    Turk J Pediatr; 2006; 48(2):109-14. PubMed ID: 16848108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Kawasaki disease: report of two cases and literature review.
    Sève P; Stankovic K; Smail A; Durand DV; Marchand G; Broussolle C
    Semin Arthritis Rheum; 2005 Jun; 34(6):785-92. PubMed ID: 15942913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of Kawasaki syndrome by intravenous gamma globulins. A medium-term clinical and paraclinical study of 5 cases].
    Lebranchu Y; Despert F; Borderon JC; Bloc D; Renoux M; Bardos P; Laugier J
    Ann Pediatr (Paris); 1986 Nov; 33(9):809-13. PubMed ID: 3492169
    [No Abstract]   [Full Text] [Related]  

  • 9. Neonatal Kawasaki disease with multiple coronary aneurysms and thrombocytopenia.
    Thapa R; Pramanik S; Dhar S; Kundu R
    Pediatr Dermatol; 2007; 24(6):662-3. PubMed ID: 18035996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of liposomal encapsulated superoxide dismutase on patients with Kawasaki disease.
    Somiya K; Niwa Y; Fukami S; Michelson AM
    Prog Clin Biol Res; 1987; 250():573-5. PubMed ID: 3423078
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzyme release and O2 production of neutrophils and vascular lesions in gamma globulin therapy of Kawasaki disease.
    Okazaki T; Sakatani T; Sasagawa S; Ohta H; Ohnishi H; Suzuki K
    Prog Clin Biol Res; 1987; 250():557-8. PubMed ID: 3423073
    [No Abstract]   [Full Text] [Related]  

  • 12. Serum thrombopoietin levels in Kawasaki disease.
    Miura N; Terai M; Meng YG; Sato T; Niimi H
    Br J Haematol; 1998 Feb; 100(2):387-8. PubMed ID: 9488632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral necrotizing microvasculitis in a patient affected by Kawasaki disease.
    Scardina GA; Fucà G; Carini F; Valenza V; Spicola M; Procaccianti P; Messina P; Maresi E
    Med Oral Patol Oral Cir Bucal; 2007 Dec; 12(8):E560-4. PubMed ID: 18059239
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis, tumor necrosis factor-alpha and procoagulant factors in coronary artery giant aneurysm of a fatal infantile Kawasaki disease.
    Pucci A; Martino S; Celeste A; Linari A; Tibaldi M; Camosso E; Muscio M; Barattia G; Riva C; Bartoloni G
    Cardiovasc Pathol; 2008; 17(3):186-9. PubMed ID: 18402791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD84 is markedly up-regulated in Kawasaki disease arteriopathy.
    Reindel R; Bischof J; Kim KY; Orenstein JM; Soares MB; Baker SC; Shulman ST; Perlman EJ; Lingen MW; Pink AJ; Trevenen C; Rowley AH
    Clin Exp Immunol; 2014 Jul; 177(1):203-11. PubMed ID: 24635044
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atypical relapsing course of Kawasaki disease with hemorrhagic serous effusions and hepatic dysfunction.
    Elizabeth KE; Ahamed MZ; Praveen KS
    Indian Pediatr; 2007 Oct; 44(10):785-7. PubMed ID: 17998582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Huang CF; Wang L; Hwang KP; Yang KD
    Pediatr Allergy Immunol; 2009 May; 20(3):266-72. PubMed ID: 19438983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Facial palsy in Kawasaki disease: report of two cases.
    Li ST; Chiu NC; Ho CS; Chen MR
    Acta Paediatr Taiwan; 2008; 49(1):24-7. PubMed ID: 18581725
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Analysis of blood neuraminidase activities and free sialic acid, with special reference to the fluctuations in Kawasaki disease].
    Yamada K; Meguro T; Miyaji Y; Mori N; Inagaki M; Tomita K; Taki M; Miura T; Saito N
    Rinsho Byori; 1983 Mar; Suppl 54():200-2. PubMed ID: 6887578
    [No Abstract]   [Full Text] [Related]  

  • 20. Persistent monocytosis after intravenous immunoglobulin therapy correlated with the development of coronary artery lesions in patients with Kawasaki disease.
    Kuo HC; Wang CL; Liang CD; Yu HR; Chen HH; Wang L; Yang KD
    J Microbiol Immunol Infect; 2007 Oct; 40(5):395-400. PubMed ID: 17932598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.